Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.14
1% from low
Exchange
OTC Link
OS
Borrow rate
8.93%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $317.7K | $161.1K | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $247.5K | $120.0K | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $70.2K | $41.0K | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | 22.1% | 25.5% | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$762.4K | −$4.6M | −$2.5M | −$1.6M | −$1.1M | −$996.9K | −$673.8K | −$1.0M |
| EBITDA | −$723.8K | −$4.2M | −$3.5M | −$2.5M | −$1.3M | −$201.4K | −$3.4M | −$1.0M |
| Net income | −$738.5K | −$4.7M | −$5.5M | −$4.5M | −$2.7M | −$1.3M | −$4.2M | −$1.0M |
| Net margin | — | -1468.2% | -3386.2% | — | — | — | — | — |
| EPS (diluted) | -0.38 | -1.35 | -1.45 | -1.18 | -0.59 | -0.23 | -0.67 | -0.08 |
Annual figures · source: Financial Modeling Prep
WAVERUNNER CAPITAL INC
No one on the platform currently holds CHMJF.
No tracked institution reports a position in CHMJF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-01-10 | 1-for-15reverse |
| 2024-06-24 | 1-for-10reverse |
No one on the platform has traded CHMJF yet.
| $101130 |
| — |
| LTUSLotus Pharmaceuticals, Inc. | $0.00 | +0.00% | $85055 | — |
| OWVIOne World Ventures, Inc. | $0.00 | +0.00% | $167843 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.